UBS Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-923
| Closed | -$3.62K | – | 9202 |
|
|
2023
Q3 | $3.62K | Buy |
923
+663
| +255% | +$2.6K | ﹤0.01% | 6390 |
|
|
2023
Q2 | $845 | Sell |
260
-140
| -35% | -$455 | ﹤0.01% | 7002 |
|
|
2023
Q1 | $1.45K | Buy |
400
+172
| +75% | +$622 | ﹤0.01% | 7639 |
|
|
2022
Q4 | $7.35K | Buy |
228
+97
| +74% | +$3.13K | ﹤0.01% | 7711 |
|
|
2022
Q3 | $5K | Buy |
+131
| New | +$5K | ﹤0.01% | 8173 |
|
|
2022
Q1 | – | Sell |
-629
| Closed | -$76K | – | 9929 |
|
|
2021
Q4 | $76K | Buy |
629
+572
| +1,004% | +$69.1K | ﹤0.01% | 5461 |
|
|
2021
Q3 | $8K | Sell |
57
-70
| -55% | -$9.83K | ﹤0.01% | 7101 |
|
|
2021
Q2 | $35K | Sell |
127
-49
| -28% | -$13.5K | ﹤0.01% | 5705 |
|
|
2021
Q1 | $38K | Sell |
176
-43
| -20% | -$9.28K | ﹤0.01% | 5799 |
|
|
2020
Q4 | $53K | Buy |
219
+158
| +259% | +$38.2K | ﹤0.01% | 5146 |
|
|
2020
Q3 | $6K | Sell |
61
-175
| -74% | -$17.2K | ﹤0.01% | 6372 |
|
|
2020
Q2 | $23K | Sell |
236
-166
| -41% | -$16.2K | ﹤0.01% | 5632 |
|
|
2020
Q1 | $30K | Sell |
402
-452
| -53% | -$33.7K | ﹤0.01% | 5322 |
|
|
2019
Q4 | $69K | Buy |
854
+201
| +31% | +$16.2K | ﹤0.01% | 5147 |
|
|
2019
Q3 | $80K | Buy |
653
+470
| +257% | +$57.6K | ﹤0.01% | 4980 |
|
|
2019
Q2 | $33K | Buy |
183
+174
| +1,933% | +$31.4K | ﹤0.01% | 5404 |
|
|
2019
Q1 | $2K | Sell |
9
-319
| -97% | -$70.9K | ﹤0.01% | 6645 |
|
|
2018
Q4 | $85K | Buy |
328
+222
| +209% | +$57.5K | ﹤0.01% | 4788 |
|
|
2018
Q3 | $26K | Buy |
106
+75
| +242% | +$18.4K | ﹤0.01% | 5733 |
|
|
2018
Q2 | $7K | Buy |
+31
| New | +$7K | ﹤0.01% | 6434 |
|